The Daily Mirror says a flagship Tory crime bill gets tough on the abuse of statues, while failing to mention violence against women. Under the plans the maximum sentence for defacing monuments will increase from three months to 10 years. Rape sentences start at five, the paper adds.
UK and European regulators have defended the Oxford-AstraZeneca COVID vaccine as five more countries stopped using it over unconfirmed links to blood clots. The European regulator insisted the benefits of the jab “outweigh the risks of side-effects”, writes The Times.Read more on this story here.
The Daily Star says former ITV presenter Piers Morgan has got into a Twitter spat with Jedward.
Boris Johnson has insisted the Oxford-AstraZeneca vaccine is safe after a host of EU countries, including Germany, France, Italy and Spain, suspended using it, with the Daily Express saying the mass revolt was criticised as likely to do “more harm than good”.
The Daily Mail reports European leaders have been accused of risking lives by suspending use of the Oxford-AstraZeneca COVID-19 jab while reports of blood clots were investigated. Scientists have insisted all the evidence pointed to the handful of adverse cases being coincidental.
The EU’s coronavirus vaccination drive has been thrown into fresh turmoil after major European nations suspended the use of the Oxford-AstraZeneca jab over blood clot fears, according to The Daily Telegraph.
Europe’s medicines regulator has moved to stifle concern about the Oxford-AstraZeneca vaccine, saying the benefits outweigh the risks after Germany, France, Italy and Spain temporarily halted its use over reported incidents of blood clots, according to The Guardian.
European countries including Germany, France, Italy and Spain have suspended use of the Oxford-AstraZeneca vaccine, even though medicines regulators and the World Health Organisation say there is no evidence of problems, reports the international edition of the Financial Times.
As several European countries halt administering the Oxford-AstraZeneca vaccine over blood clot fears, with 37 “thromboembolic events” recorded among 17 million recipients, the company said the incidence of clots was much lower than would be expected to occur naturally in a population of this size, says The Independent.
